你即將離開本站

並前往https://www.cancernetwork.com/view/first-line-olaparib-bevacizumab-maintenance-combo-approved-in-china-for-hrd-advanced-ovarian-cancer

First-Line Olaparib/Bevacizumab Maintenance Combo ...

... 57.3 months with bevacizumab alone in patients with HRD-positive advanced ovarian cancer including those with a BRCA mutation (HR 0.62; ...

確定！ 回上一頁

查詢 「MAYO HR」的人也找了：

  1. mayo老闆
    2.
  2. mayo評價
    3.
  3. MAYO
    4.
  4. mayo鼎恒數位科技ptt
    5.
  5. mayo創辦人
    6.
  6. MAYO 104
    7.
  7. 鼎恒數位科技天眼通
    8.
  8. mayo鼎恒數位科技人資系統
    9.